MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

Pfizer

Uždarymo kaina

SektoriusSveikatos priežiūra

25.68 -2.21

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

25.63

Max

26.47

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-45M

2.9B

Pardavimai

938M

15B

P/E

Sektoriaus vid.

13.984

37.257

Pelnas, tenkantis vienai akcijai

0.78

Dividendų pajamingumas

6.21

Pelno marža

19.982

Darbuotojai

81,000

EBITDA

266M

5.3B

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+8.6% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

6.21%

2.94%

Kitas uždarbis

2025-11-04

Kitas dividendų mokėjimo data

2025-12-01

Kita Ex Dividend data

2025-11-07

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

16B

150B

Ankstesnė atidarymo kaina

27.89

Ankstesnė uždarymo kaina

25.68

Naujienos nuotaikos

By Acuity

36%

64%

150 / 371 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

Pfizer Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-10-01 08:54; UTC

Pagrindinės rinkos jėgos

Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site

2025-09-30 15:07; UTC

Pagrindinės rinkos jėgos

Pfizer Shares Rise After WSJ Reports Company Will Lower Drug Costs

2025-09-22 14:54; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- 2nd Update

2025-09-22 11:51; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- Update

2025-09-22 11:09; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion

2025-09-22 10:13; UTC

Pagrindinės rinkos jėgos
Įsigijimai, susijungimai, perėmimai

Metsera Shares Leap Premarket on Report of Takeover by Pfizer

2025-09-22 07:42; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer Nears $7.3 Billion Metsera Deal, FT Says, Citing Sources

2025-08-05 11:34; UTC

Uždarbis

Pfizer Boosts 2025 Adjusted EPS Outlook Following 2Q Gains

2025-09-22 15:17; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer Jumps Back into the Weight-Loss Race With $4.9B Acquisition -- Barrons.com

2025-09-22 13:43; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- Update

2025-09-22 11:26; UTC

Įsigijimai, susijungimai, perėmimai

These Stocks Are Moving the Most Today: Fox, Coinbase, Metsera, Pfizer, Kenvue, Anywhere Real Estate, Premier, and More -- Barrons.com

2025-09-22 11:26; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- WSJ

2025-09-22 10:48; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer: Metsera Deal Adds Four Clinical-Stage Incretin, Amylin Programs to Pipeline >PFE MTSR

2025-09-22 10:47; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer: Metsera Deal Includes Contingent Value Rights Worth Up to Additional $22.50/Share >PFE MTSR

2025-09-22 10:46; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer: Metsera Deal Has Initial Enterprise Value of $4.9 Billion >PFE MTSR

2025-09-22 10:45; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer to Pay Initial $47.50/Share for Metsera >PFE MTSR

2025-09-22 10:45; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer to Acquire Metsera and Its Next-Generation Obesity Portfolio >PFE MTSR

2025-09-22 09:12; UTC

Karštos akcijos

Stocks to Watch Monday: Nippon Steel, Porsche, Infosys, Metsera -- WSJ

2025-08-05 20:44; UTC

Uždarbis

These Stocks Moved the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

2025-08-05 18:20; UTC

Uždarbis

Pfizer Stock Rises as Earnings Smash Expectations. But These Challenges Remain. -- Barrons.com

2025-08-05 18:17; UTC

Uždarbis

These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

2025-08-05 16:04; UTC

Rinkos pokalbiai

Pfizer's New Tax Rate Helps Boost Adj EPS Outlook -- Market Talk

2025-08-05 15:25; UTC

Uždarbis

Correction to These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Caterpillar, BP, and More -- Barrons.com

2025-08-05 13:56; UTC

Uždarbis

Pfizer Stock Rises as Earnings Smash Expectations. But These Challenges Remain. -- Barrons.com

2025-08-05 11:43; UTC

Uždarbis

Pfizer Stock Pops as Earnings Smash Expectations. Guidance Hiked in Face of Tariffs. -- Barrons.com

2025-08-05 11:27; UTC

Uždarbis

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

2025-08-05 10:57; UTC

Uždarbis

Pfizer Stock Pops as Earnings Smash Expectations. Why the Outlook Has Been Hiked. -- Barrons.com

2025-08-05 10:55; UTC

Uždarbis

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

2025-08-05 10:53; UTC

Uždarbis

Pfizer Boosts 2025 Profit Estimate In A Sign Of 'Confidence' -- MarketWatch

2025-08-05 10:51; UTC

Uždarbis

Pfizer: On Track to Deliver About $7.2B Overall Cost Savings From Cost-Improvement Initiatives b/ End of 2027 >PFE

Akcijų palyginimas

Kainos pokytis

Pfizer Prognozė

Kainos tikslas

By TipRanks

8.6% į viršų

12 mėnesių prognozė

Vidutinis 28.53 USD  8.6%

Aukščiausias 34 USD

Žemiausias 24 USD

Remiantis 17 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Pfizer kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

17 ratings

4

Pirkti

12

Laikyti

1

Parduoti

Techninis įvertinimas

By Trading Central

22.855 / 23.85Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

150 / 371 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
help-icon Live chat